AI assistant
Sending…
CONMED Corp — Director's Dealing 2022
Jun 22, 2022
31971_dirs_2022-06-21_108a4450-c351-4c8d-968a-c7b948388c2c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2022-04-01
Reporting Person: Lalomia Brent (Vice President QA and RA)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Rsus (restricted Stock Units) | $0 | 2029-06-17 | Common Stock (1000) | Direct | |
| Rsus (restricted Stock Units) | $0 | 2032-03-07 | Common Stock (300) | Direct |
Footnotes
F1: Administrative error with broker report.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F3: Administrative error with broker report.
More from CONMED Corp
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18